JP Morgan Downgrades Johnson & Johnson to “Neutral” on Valuation Call (JNJ)
JP Morgan analysts downgraded health care products maker Johnson & Johnson (JNJ) on Monday on a valuation call.
The analysts downgraded JNJ from “Overweight” to “Neutral” and see shares reaching $83. This target suggests a 1% upside to Friday’s closing price of $82.04.
Johnson & Johnson shares were down 50 cents, or -0.61%, during pre-market trading on Monday. The stock is up +17.03% year-to-date.
The Bottom Line
Shares of Johnson & Johnson (JNJ) have a dividend yield of 2.97% based on Friday’s closing price of $82.04 and the company’s annualized dividend payout of $2.44 per share.
Johnson & Johnson (JNJ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.
Get FREE Dividend Tips, Updates & MoreWe respect your privacy
- Powerful dividend insights sent every weekday morning
- Gain instant access to actionable investing tips
- Strategically grow your portfolio’s profitability